Adherence to community-based lung cancer screening in the Yorkshire Lung Screening Trial

被引:0
|
作者
Ahmad, Sarah Q. [1 ]
Pesola, Francesca [2 ]
Crosbie, Philip A. J. [3 ]
Gabe, Rhian [2 ]
Hancock, Neil [4 ]
Kennedy, Martyn P. T. [1 ]
Marshall, Catriona [4 ]
Quaife, Samantha L. [5 ]
Rogerson, Suzanne [6 ]
Simmonds, Irene [4 ]
Callister, Matthew E. J. [1 ,4 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Dept Resp Med, Leeds, England
[2] Queen Mary Univ London, Wolfson Inst Populat Hlth, Ctr Evaluat & Methods, London, England
[3] Univ Manchester, Fac Biol Med & Hlth, Div Immunol Immun Infect & Resp Med, Manchester, England
[4] Univ Leeds, Leeds Inst Hlth Sci, Leeds, England
[5] Queen Mary Univ London, Wolfson Inst Populat Hlth, Ctr Prevent Detect & Diag, London, England
[6] Leeds Teaching Hosp NHS Trust, Dept Res & Innovat, Leeds, England
关键词
Low dose computed tomography screening; Lung cancer screening; Adherence;
D O I
10.1016/j.lungcan.2025.108086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Lung cancer screening saves lives by detecting cancers early, but continued adherence to screening rounds is required for participants to experience the maximum clinical benefit. Here we describe factors associated with screening adherence in the Yorkshire Lung Screening Trial. Methods: All eligible individuals following baseline (prevalent) screening were invited for a biennial incident screen in a community setting. Participants were contacted by phone (up to two attempts) to arrange an appointment or sent a pre-arranged appointment letter if non-contactable. Characteristics of attenders versus non-attenders were compared using univariate and multivariable models. Results: Of 6,650 individuals who attended baseline screening, 5,975 were eligible for the second round. The mean age of those eligible was 70.5 years, 45.2 % were female, 31.7 % were from the most socio-economically deprived quintile and 33.9 % reported current smoking at the time of the baseline scan. Of these, 5,184 (86.8 %) attended their second screen and 791 (13.2 %) did not. Factors associated with lower attendance following multivariable analysis were socio-economic deprivation (OR 0.78, 95 % CI 0.60-1.02, most versus least deprived quintile) and current smoking (OR 0.57, 95 % CI 0.48-0.66, current versus previously quit). Sex, age, and ethnicity were not associated with attendance. Attendance was more likely in people who had an indeterminate (OR 2.10, 95 % CI 1.61-2.73; n = 871) or positive (OR 3.16, 95 % CI 0.98-10.19; n = 60) baseline scan compared to a negative baseline scan. Discussion: Adherence was good overall but lower adherence amongst people who currently smoke and those from deprived populations is a concern due to their greater risk of lung cancer death. Further research is needed into interventions that increase adherence in these high-risk populations.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
    Crosbie, Philip A. J.
    Gabe, Rhian
    Simmonds, Irene
    Hancock, Neil
    Alexandris, Panos
    Kennedy, Martyn
    Rogerson, Suzanne
    Baldwin, David
    Booton, Richard
    Bradley, Claire
    Darby, Mike
    Eckert, Claire
    Franks, Kevin N.
    Lindop, Jason
    Janes, Sam M.
    Moller, Henrik
    Murray, Rachael L.
    Neal, Richard D.
    Quaife, Samantha L.
    Upperton, Sara
    Shinkins, Bethany
    Tharmanathan, Puvan
    Callister, Matthew E. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (05)
  • [2] Factors influencing screening adherence in the Yorkshire Lung Screening Trial
    Ahmad, Sarah
    Pesola, Francessca
    Crosbie, Philip
    Gabe, Rhian
    Hancock, Neil
    Kennedy, Martyn
    Marshall, Catriona
    Rogerson, Suzanne
    Simmonds, Irene
    Callister, Matthew
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] Community-based lung cancer screening adherence to Lung-RADS recommendations.
    Kim, Roger
    Rendle, Katharine A.
    Neslund-Dudas, Christine
    Greenlee, Robert T.
    Burnett-Hartman, Andrea N.
    Honda, Stacey A.
    Simoff, Michael J.
    Croswell, Jennifer M.
    Ritzwoller, Debra P.
    Vachani, Anil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK
    Robbins, Hilary A.
    Zahed, Hana
    Lebrett, Mikey B.
    Balata, Haval
    Johansson, Mattias
    Sharman, Anna
    Evans, D. Gareth
    Crosbie, Emma J.
    Booton, Richard
    Landy, Rebecca
    Crosbie, Philip A. J.
    LUNG CANCER, 2022, 171 : 61 - 64
  • [5] Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk
    Crosbie, Philip A. J.
    Gabe, Rhian
    Simmonds, Irene
    Kennedy, Martyn
    Rogerson, Suzanne
    Ahmed, Nazia
    Baldwin, David R.
    Booton, Richard
    Cochrane, Ann
    Darby, Michael
    Franks, Kevin
    Hinde, Sebastian
    Janes, Sam M.
    Macleod, Una
    Messenger, Mike
    Moller, Henrik
    Murray, Rachael L.
    Neal, Richard D.
    Quaife, Samantha L.
    Sculpher, Mark
    Tharmanathan, Puvanendran
    Torgerson, David
    Callister, Matthew E. J.
    BMJ OPEN, 2020, 10 (09):
  • [6] Improving Annual Adherence in a Community Based Lung Cancer Screening Program
    Braithwaite, K. A.
    Schneider, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S810 - S810
  • [7] Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study
    Lam, V. K.
    Scott, R. J.
    Billings, P.
    Cabebe, E.
    Young, R. P.
    PREVENTIVE MEDICINE REPORTS, 2021, 23
  • [8] Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment
    Scobie, Hannah
    Robb, Kathryn A.
    Macdonald, Sara
    Harrow, Stephen
    Sullivan, Frank
    JOURNAL OF MEDICAL SCREENING, 2024, 31 (01) : 46 - 52
  • [9] Community-based lung cancer screening navigation for populations at high risk
    Tsosie, Ursula
    DeCell, Katie
    Anderson, Nicolas
    Snidarich, Madison
    Omernik, Brandon
    Murphy, Nicholas
    Triplette, Matthew
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [10] Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme
    Balata, H.
    Evison, M.
    Booton, R.
    Crosbie, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S780 - S780